Cite
HARVARD Citation
Phillips, A. et al. (2019). Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Lancet. 6 (2), pp. e116-e127. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Phillips, A. et al. (2019). Risks and benefits of dolutegravir-based antiretroviral drug regimens in sub-Saharan Africa: a modelling study. Lancet. 6 (2), pp. e116-e127. [Online].